Company Filing History:
Years Active: 2008-2012
Title: David E Steinmeyer: Innovator in Recombinant Protein Technologies
Introduction
David E Steinmeyer is a notable inventor based in Clarkson Valley, MO (US). He has made significant contributions to the field of recombinant protein technologies, holding 2 patents that focus on the preparation of growth hormones and their antagonists.
Latest Patents
Steinmeyer's latest patents include a method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities. This invention is directed to recombinant methods for producing a desired polypeptide with reduced isoform impurities. Specifically, it addresses the preparation of growth hormone and its antagonist, pegvisomant, while minimizing trisulfide and des-phe isoform impurities. Another patent focuses on a process for decreasing aggregate levels of pegylated protein, which also utilizes recombinant methods to yield a polypeptide product with reduced aggregate levels.
Career Highlights
David E Steinmeyer is currently associated with Pfizer Corporation, where he applies his expertise in recombinant technologies. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of therapeutic proteins.
Collaborations
Steinmeyer has collaborated with notable colleagues, including Denis M Boyle and John J Buckley, to further enhance the research and development of innovative protein technologies.
Conclusion
David E Steinmeyer's contributions to recombinant protein technologies have made a significant impact in the field, showcasing his dedication to innovation and excellence in science.